These studies have identified somatic mutations in the proto-oncogene KRAS as a hallmark of pancreatic cancers in that more than 90% of pancreatic cancer cases have mutations in this gene [8, 10, 11]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.